Diagnostic yield of colonoscopy in Lynch Syndrome
We demonstrate a high adenoma burden with distinct phenotypic and gene-specific characteristics in a UK LS population undergoing high quality surveillance
fg.bmj.com/content/earl...
@horganroberta.bsky.social
Thriving with polyposis. Patient advocate and PPI rep Lynch Syndrome Ireland Group. Hereditary cancer awareness & support. Passionate about cancer research and PPI. Tries a bit of gardening ๐ฑ๐บ๐
Diagnostic yield of colonoscopy in Lynch Syndrome
We demonstrate a high adenoma burden with distinct phenotypic and gene-specific characteristics in a UK LS population undergoing high quality surveillance
fg.bmj.com/content/earl...
Weโre proud to present the current Council members of The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), driving progress in research, collaboration, and patient care worldwide.
Learn more about us๐ shorturl.at/6cyJV
#Genetics #GIHealth #HereditaryGICancer #InSiGHT
November is Pancreatic Cancer Awareness Month ๐
Itโs the deadliest of the common cancers due to late detection.
Researchers stress genetic testing - hereditary risk matters. Know your family history. Advocate for early detection. ๐
Read more ๐ shorturl.at/eKuTB
#PancreaticCancer #GeneticTesting
I'm sure you did more than okay. I'm sure you were brilliant! I'm in awe of your incredible advocacy Tony. You've always been a powerful and consistent voice for prostate cancer awareness and support ๐๐
25.10.2025 13:32 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0I am constantly bouncing from imminent death to endless life (mostly metaphorically, but sometimes literally) and the push and pull of it is exhausting.
www.medicalindependent.ie/comment/opin...
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jakob Hedberg of Uppsala๐ธ๐ช
dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy?
Confirmed great data from #8HW trial at #ESMO25 with the combination NIVO+IPI confirms the standard of care option in 1st line MSI-H/dMMR mCRC patients @oncodaily.bsky.social
20.10.2025 07:11 โ ๐ 3 ๐ 2 ๐ฌ 0 ๐ 0And I'll bet you smashed it, Tony! You're a powerhouse ๐๐ช
23.10.2025 20:01 โ ๐ 1 ๐ 0 ๐ฌ 1 ๐ 0Delighted with my presentation at #ESMO25 for @Medscape. Itโs such a privilege to be given the patient voice and make the voices of the thousands of men that @TackleProstate support, heard. Now though I found a beer garden! Wonโt be here long cos itโs freezing!
19.10.2025 15:12 โ ๐ 7 ๐ 1 ๐ฌ 1 ๐ 0#ESMO25: Clinically relevant survival benefits reported in platinum-resistant #OvarianCancer with pembrolizumab plus weekly paclitaxel with or without bevacizumab in ENGOT-ov65/KEYNOTE-B96 #ESMODailyReporter ๐https://ow.ly/MIjA50XeuR3
#immunotherapy
#ESMO25 Wonderful to see so many โ๏ธ colleagues at @myesmo.bsky.social #ClimateChange task force meeting
Encouraging to see such interest in ๐ Sustainability ๐ณ
@cancertrialsie.bsky.social @irishdocsenv.bsky.social
#ESMO25: Regular exercise has a significant impact on patient survival, but how can physical activity be integrated into the patient journey? Pr Michel Ducreux considers barriers and possible solutions.
#ESMODailyReporter๐ https://ow.ly/zect50Xezeq
#CancerCare #CancerManagement
Powerful message from Dr Anne-Marie Baird (TCD, ILCC) at #ESMO25 on gender bias in cancer care:
๐ Recognise โ bias distorts outcomes
๐ง Redesign โ integrate sex & gender in every step
๐ Report โ transparency in data, trials & diagnostics
#CancerEquity #PatientAdvocacy #LungCancer
๐๏ธ Check out my short #ESMODailyReporter editorial on early data from a first-in-human TCR-T therapy targeting KRAS G12V in advanced pancreatic & colorectal cancer, presented today by Dr Bai from Zhejiang University.
#ESMO25
#CellTherapy
#ESMOAmbassadors
@myesmo.bsky.social
#ESMO25: Are personalised #CancerVaccines the next frontier or an elusive goal? Catherine Wu discusses the exciting potential of genomics-guided personalised vaccines and some of the related challenges.
#ESMODailyReporter ๐ https://ow.ly/aMxi50Xgn37
#ImmunoOncology
๐งฌ October = National Family History Month!
Read the blog๐๐ tinyurl.com/bdhjjv83
Reminding us that even in the era of๐งฌtesting, ๐ชhistory is still the foundation of hereditary cancer care. Asking the rightโ& sharing results can save lives across generations.
#HereditaryGICancer
๐ฃMissed #CGAIGC25 this year?
Catch the short discussion between Prof Sir John Burn & @swatipatelmd.bsky.social sharing long-awaited CaPP3 results, a follow-up to the landmark CaPP2 trial showing aspirinโs ๐role in lowering cancer risk in #LynchSyndrome
๐ tinyurl.com/msshdb5b
#HereditaryGICancer
Congratulations to our UCAN Ireland members @miriamstaunton.bsky.social & @cynthiacravo.bsky.social on becoming EUPATI Fellows ๐
A wonderful achievement and testament of your dedication to patient advocacy๐๐๐
#ExpertPatientVoices #CancerTherapeutics #Innovation #EUPATI
The Irish Cancer Society has said there is a complacent notion that Ireland is doing well in terms of cancer treatment.
22.10.2025 11:03 โ ๐ 11 ๐ 3 ๐ฌ 0 ๐ 0lynchsyndromeireland.com/2025/09/06/r... @kevinmonahan.bsky.social
06.09.2025 09:42 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0September is #OvarianCancer Awareness Month, a time to spotlight a disease that remains one of the deadliest gynecologic cancers. In 2025, > 20,000 women in the U.S. will be diagnosed with OVCA, and roughly 60% of those diagnosed will die from it!
#gyncsm #womenshealth #medsky #hereditarycancer
Having reliable access to safe, affordable medicines ๐ is essential for everyone.
We are urging policymakers to prioritise these issues and encourage manufacturers to produce the medicines in demand.
โก๏ธ www.sandoz.com/makingaccess...
#AccessToMedicines #HealthEquity @helloeacr.bsky.social